Top 10 search results for "Trastuzumab" in Treatments. To see all results and access other features, sign up for free.

Trastuzumab

Overview
Trastuzumab is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat metastatic breast cancer in cases where tumors overexpress the HER2 protein and one or more chemotherapy… read more

Herceptin (Trastuzumab)

Overview
Herceptin is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat metastatic breast cancer in cases where tumors overexpress the HER2 protein and one or more chemotherapy… read more

Ogivri (Trastuzumab-dkst)

Overview
Ogivri is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat breast cancer in cases where tumors overexpress the HER2 protein. Ogivri is also known by its drug name,… read more

Herzuma (Trastuzumab-Pkrb)

Overview
Herzuma is approved by the U.S. Food and Drug Administration (FDA) for the treatment of HER2-overexpressing breast cancer. It is prescribed for people with both early-stage and metastatic (cancer that has spread)…

Kanjinti (Trastuzumab-Anns)

Overview
Kanjinti is approved by the U.S. Food and Drug Administration (FDA) for the treatment of HER2-overexpressing breast cancer. This medication is indicated for people with tumors that produce high levels of the HER2…

Trazimera (Trastuzumab-Qyyp)

Overview
Trazimera is approved by the U.S. Food and Drug Administration (FDA) for the treatment of HER2-overexpressing breast cancer. Individuals who are eligible for Trazimera must have breast cancer that overexpresses…

Ontruzant (Trastuzumab-Dttb)

Overview
Ontruzant is approved by the U.S. Food and Drug Administration (FDA) for HER2-overexpressing breast cancer. Ontruzant is prescribed for both early-stage and metastatic HER2-positive breast cancer. Individuals are…

Ado-Trastuzumab Emtansine

Overview
Ado-trastuzumab emtansine is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat some cases of HER2-positive, metastatic breast cancer. Ado-trastuzumab emtansine may be… read more

Kadcyla (Ado-Trastuzumab Emtansine)

Overview
Kadcyla is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat some cases of HER2-positive, metastatic breast cancer. Kadcyla may be prescribed in cases where trastuzumab and a… read more

Herceptin Hylecta (Trastuzumab/Hyaluronidase-oysk)

Overview
Herceptin Hylecta is a prescription drug approved by the U.S. Food and Drug Administration (FDA) as an adjuvant treatment for metastatic breast cancer in cases where tumors overexpress the HER2 protein and one… read more

MyBCTeam is the social network for women facing breast cancer. Get the emotional support you need from others like you, and gain practical advice and insights on managing treatment or therapies for breast cancer. MyBCTeam is the only social network where you can truly connect, make real friendships, and share daily ups and downs in a judgement-free place.

MyBCTeam is not a medical referral site and does not recommend or endorse any particular provider or medical treatment. No information on MyBCTeam should be construed as medical and/or health advice.